Average Co-Inventor Count = 10.59
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (13 from 822 patents)
2. Other (1 from 832,912 patents)
3. Abbott Laboratories Corporation (1 from 4,179 patents)
4. Abbvie Bahamas Limited (6 patents)
15 patents:
1. 11767310 - Nicotinamide RIPK1 inhibitors
2. 11344621 - Interleukin-13 binding proteins
3. 10508113 - Inhibitors of tyrosine kinase 2 mediated signaling
4. 10160748 - Indazolones as modulators of tnf signaling
5. 10106501 - Nuclear receptor modulators
6. 10093733 - LRP-8 binding dual variable domain immunoglobulin proteins
7. 10086076 - Interleukin-13 binding proteins
8. 9592293 - Interleukin-13 binding proteins
9. 9365579 - Tricyclic compounds
10. 9115151 - Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereof
11. 8962629 - Tricyclic compounds
12. 8785639 - Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof
13. 8604177 - Interleukin-13 binding proteins
14. 8008481 - Indazole compounds
15. 7915388 - Interleukin-13 binding proteins